Profusa, Inc.

Profusa, Inc., trading under the ticker NVAC, is a healthcare-technology company focused on implantable continuous biosensor technology for real-time body-chemistry monitoring. The company filed a 10-Q with the SEC on November 20, 2023, covering its quarterly financial results as a post-combination public entity following its SPAC merger process. Profusa operates in the medical devices and digital health sector, developing subcutaneous biosensors designed to measure physiological biomarkers continuously. The filing reflects the company's ongoing obligations as a reporting issuer in the U.S. public markets. For full filing history, merger details, shareholder data, and real-time SPAC analytics on NVAC and hundreds of other vehicles, sign up for a SpacDesk account at SpacDesk.com.